PubMed ID:
20965184
Public Release Type:
Journal
Publication Year: 2011
Affiliation: Gastroenterology Section, Temple University, Philadelphia, Pennsylvania 19140, USA. henry.parkman@temple.edu
DOI:
https://doi.org/10.1053/j.gastro.2010.10.015
Authors:
Abell T,
Abell TL,
Atkinson M,
Baxter L,
Belt P,
Bernard C,
Bishop R,
Calles J,
Coleski R,
Colvin R,
Culler S,
DeVole N,
Doma S,
Donithan M,
Farrugia G,
Farrugia G,
Fordham J,
Gomez J,
Greene M,
Green M,
Hamilton F,
Hamilton F,
Hasler W,
Hasler WL,
Hejazi R,
Henry O,
Hooker J,
Isaacson M,
James S,
Kantor S,
Kedar A,
Kim W,
Koch K,
Koch KL,
Lee L,
Lee L,
Louiseau S,
Lurken M,
Lydecker A,
Lytes V,
Mann P,
Marincek A,
McCallum RW,
McCallum RW,
McNair V,
Miriel L,
National Institute of Diabetes and Digestive and Kidney Diseases Gastroparesis Clinical Research Consortium,
Nguyen L,
Nguyen L,
Palit A,
Parker S,
Parkman HP,
Parkman HP,
Pasricha PJ,
Pasricha PJ,
Pillor E,
Ponsetto C,
Pruett S,
Ramzan Z,
Sachdeva P,
Sarosiek I,
Shetler K,
Simmons K,
Smith M,
Snape W,
Snape WJ,
Spree D,
Sternberg A,
Stuart P,
Tonascia J,
Tonascia J,
Torrance R,
Ullah N,
Unalp-Arida A,
Unalp-Arida A,
Van Natta M,
Van Raaphorst R,
Vasquez D,
Vaughn I,
Vega N,
Wilson L,
Yates K,
Yates K
Studies:
Gastroparesis Clinical Research Consortium
,
Nortriptyline for Idiopathic Gastroparesis
Idiopathic gastroparesis (IG) is a common but poorly understood condition with significant morbidity. We studied characteristics of patients with IG enrolled in the National Institute of Diabetes and Digestive and Kidney Diseases Gastroparesis Clinical Research Consortium Registry.